Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Does acyclovir increase serum lithium levels?

R K Sylvester1, J Leitch, C Granum

  • 1MeritCare Hospital, North Dakota State University, Fargo 58105, USA.

Pharmacotherapy
|May 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reducing surgical mortality in Scotland by use of the WHO Surgical Safety Checklist.

The British journal of surgery·2019
Same author

Training anaesthetists about quality improvement.

Anaesthesia·2014
Same author

Yunis-varon syndrome: further delineation of cardiovascular and endocrine outcome.

American journal of medical genetics. Part A·2014
Same author

A pilot improvement project in hospital-based oral healthcare: improving caries risk assessment documentation.

British dental journal·2012
Same author

Electrochemical and PM-IRRAS a glycolipid-containing biomimetic membrane prepared using Langmuir-Blodgett/Langmuir-Schaefer deposition.

Langmuir : the ACS journal of surfaces and colloids·2008
Same author

Intersatellite range monitoring using optical interferometry.

Applied optics·2008

Intravenous acyclovir may increase lithium levels in patients, potentially causing toxicity. Healthcare providers should monitor lithium levels closely during concurrent acyclovir therapy.

Area of Science:

  • Nephrology
  • Pharmacology
  • Infectious Diseases

Background:

  • Lithium carbonate is a common mood stabilizer requiring careful monitoring due to its narrow therapeutic index.
  • Herpes zoster infections are often treated with antiviral medications like acyclovir.
  • Both lithium and acyclovir are renally excreted, suggesting potential pharmacokinetic interactions.

Observation:

  • A patient receiving lithium carbonate developed signs of lithium toxicity after initiating intravenous acyclovir therapy.
  • Serum lithium levels increased fourfold during the course of acyclovir administration.
  • No prior literature documented an interaction between acyclovir and lithium.

Findings:

  • High-dose intravenous acyclovir may impede the renal excretion of lithium.

Related Experiment Videos

  • This interaction can lead to elevated serum lithium concentrations and potential toxicity.
  • The mechanism may involve competition for renal clearance pathways.

    • Implications:

    • Clinicians should exercise caution when co-administering intravenous acyclovir and lithium.
    • Close monitoring of serum lithium levels and assessment for toxicity symptoms are recommended during concurrent therapy.
    • Further research is warranted to elucidate the precise mechanism and clinical significance of this drug interaction.